alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Postal Service

# DATE AND TIME:

 January 14, 2021, at 3:00 p.m.

# PLACE: 

Potomac, MD.

# STATUS: 

Closed.

# MATTERS TO BE CONSIDERED:

Thursday, January 14, 2021, at 3:00 p.m.

1. Strategic Items.

2. Administrative Items.

GENERAL COUNSEL CERTIFICATION: The General Counsel of the United States Postal Service has certified that the meeting may be closed under the Government in the Sunshine Act.

# CONTACT PERSON FOR MORE INFORMATION: 

Michael J. Elston, Secretary of the Board, U.S. Postal Service, 475 L'Enfant Plaza SW, Washington, DC 20260-1000. Telephone: (202) 268-4800.

Michael J. Elston,

Secretary.

[FR Doc. 2021-00117 Filed 1-5-21; 4:15 pm]

BILLING CODE 7710-12-P
Exhibit 31.2**Certification****Pursuant to Section 302 of the Sarbanes — Oxley Act of 2002**I, Greenfield Pitts, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Emerson Radio Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, not misleading withrespect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures as of the end of the period covered by this report based on such evaluation;andc) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and
37

 
 5. The registrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of registrant’s board of directors (or persons performingthe equivalent functions):a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant’s ability to record, process, summarize andreport financial information; andb) Any fraud, whether or not material, that involves management or other employees who havea significant role in the registrant’s internal control over financial reporting.Date:March 16, 2007       /s/ Greenfield Pitts     Greenfield Pitts    Chief Financial Officer  A signed original of this written statement required by Section 302 has been provided to EmersonRadio Corp. and will be retained by Emerson Radio Corp. and furnished to the Securities andExchange Commission or its staff upon request.
38
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-1185

JAMES CLINTON DAVIS,

Plaintiff - Appellant,

versus

HONDA OF SOUTH CAROLINA MANUFACTURING,

INCORPORATED,

Defendant - Appellee,

and

LEONARD LOWERY, Honda of South Carolina; JHON

BLACH, Honda of South Carolina; BRAD SMITH,

Honda of South Carolina,

Defendants.

Appeal from the United States District Court for the District of

South Carolina, at Florence. R. Bryan Harwell, District Judge.

(4:03-cv-03546-RBH)

Submitted: March 31, 2006 Decided: May 2, 2006

Before NIEMEYER, MOTZ, and DUNCAN, Circuit Judges.

Affirmed by unpublished per curiam opinion.
- 2 -

James Clinton Davis, Appellant Pro Se. Susan Pedrick McWilliams,

Regina Hollins Lewis, Joan Wash Hartley, NEXSEN PRUET, Columbia,

South Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
- 3 -

PER CURIAM:

James Clinton Davis appeals the district court’s order

adopting the recommendation of the magistrate judge and granting

summary judgment to the Defendant on his claims under the Americans

with Disabilities Act, 42 U.S.C. §§ 12101 to 12213 (2000) and the

Family and Medical Leave Act of 1993 (“FMLA”), 29 U.S.C. § 2601 et

seq. We have reviewed the record and find no reversible error.

Accordingly, we affirm for the reasons stated by the district

court. See Davis v. Honda of SC, No. 4:03-cv-03546-RBH (D.S.C.

Jan. 26, 2006). We dispense with oral argument because the facts

and legal contentions are adequately presented in the materials

before the court and argument would not aid the decisional process.

AFFIRMED
-       - Superintendent of Documents
      - 2023-07-14T10:10:56-0400
      - Government Publishing Office, Washington, DC 20401
      - Government Publishing Office
      - Government Publishing Office attests that this document has not been altered since it was disseminated by Government Publishing Office
#### FREEDMAN v. BADANES.

(Supreme Court, Appellate Term.

June 22, 1903.)

1. Appeal—Questions op Fact.

Where, in an action on a note, the question to be determined is whether plaintiff's assignor had performed certain conditions entitling him to recover, a finding for him, being on a question of fact, will not be disturbed.

Appeal from City Court of New York, General Term.

Action by Moses Freedman against Bernard Badanes. From a judgment for plaintiff, defendant appeals. Affirmed.

Argued before FREEDMAN, P. J., and GILDERSLEEVE and MacLEAN, JJ.

J. A. Seidman, for appellant.

Jacob Gorden, for respondent.

FREEDMAN, P. J.

This action was brought upon a promissory note executed by the defendant, payable to plaintiff’s assignor, for the sum of $500. The consideration for the note was the sale and transfer to the defendant of 10 shares of stock of the United Gas Fixture Company, owned by plaintiff’s assignor, one Backer. The note was placed in the hands of the defendant’s attorney, there to remain until Backer had complied with certain conditions embodied in a written agreement executed at the time the note was made. The question to be determined in the action was whether or not Backer had performed the conditions named in the agreement, and thereby became entitled to recover on the note. This was a question of fact, and was decided by the jury in favor of the plaintiff. The exceptions taken by the defendant during the progress of the trial are without merit, and the judgment must be affirmed.

Judgment affirmed, with costs. All concur.
Exhibit 10.4


    Exhibit
      10.4

     

    
      	 	March 16,
              2006


    

     

    FermaVir
      Pharmaceuticals, Inc.

    420
      Lexington Avenue, Suite 445

    New
      York,
      NY 10170

    


    Gentlemen:

    


    FermaVir
      Pharmaceuticals, Inc. (the “Company”) has requested that I agree to certain
      modifications of Option No. 0-FERMAVIR-05-A-002, granted to me as of February
      22, 2005 (the “NQSO Options”), which presently permit me to acquire 525,000
      shares of the Company’s common stock for $.75 per share in order to facilitate
      financing for the Company. I refer you to the Repurchase Option Agreement dated
      as of the date of this letter (the “Repurchase Agreement”) between the Company
      and Chris McGuigan. Unless otherwise defined in this letter, capitalized terms
      herein shall have the meanings assigned to them in the Repurchase
      Agreement.

    


    In
      consideration of the Company entering into the Technology Acquisition Agreement
      (the “TAA”), I agree:

    


    (a) not
      to
      exercise in excess of 52,500 of the NQSO options until the Phase I Clinical
      Trials have commenced for a product utilizing the Licensed Subject Matter (as
      reasonably determined by the Company, provided such determination will not
      be
      necessary if, following receipt of all requisite regulation approvals, human
      patients have been administered a product incorporating the Licensed Subject
      Matter). 

    


    (b) In
      the
      event the Trigger Event occurs, I agree that upon exercise of the Company’s
      Option set forth in Section 2A of the Repurchase Agreement, upon payment to
      me
      of $50,000, the Company will cancel 472,500 options to purchase the Company’s
      common stock represented by Option No. 0-FERMAVIR-05-A-002.
      In
      addition, pursuant to Section 2.4 of the TAA, within thirty (30) days after
      the
      Exercise Notice (as defined in the TAA) has become effective, the Company shall
      transfer, in exchange for the consideration set forth in Section 2.3 of the
      TAA,
      all rights, title and interest in and to the Core Technology (as defined in
      the
      TAA), without any encumbrance or lien (but subject to any development or
      research right or licenses granted by the Company prior to the Exercise Date
      (as
      defined in the TAA) and the payment of the Purchase Note (as defined in the
      TAA)), and the Company will deliver the Core Technology, including any
      documentation thereto, to the Holders or any assignee of the Holders, including,
      without limitation, University Cardiff Consultants Limited, as directed in
      the
      Exercise Notice.

     

    
      	 	Very truly yours,


      	 	 


      	 	/s/ Erik DeClercq


      	 	 


      	 	Erik
              DeClercq
EXHIBIT 32.1


Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350,


as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In connection with this quarterly report of Espey Mfg. & Electronics Corp. (the "Company") on Form 10-Q for the period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Mark St. Pierre, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





1.
The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date: November 12, 2010








/s/Mark St. PierreMark St. PierrePresident and Chief Executive Officer
EXHIBIT 11
<TABLE>
                       ANDREW CORPORATION AND SUBSIDIARIES
                        Computation of Earnings Per Share
<CAPTION>
                                          Year Ended September 30            
                                        1996      1995      1994
                                        -------   -------   -------
                                          (Amounts in thousands, 
                                           except per share data)
<S>                                     <C>       <C>       <C>
PRIMARY EARNINGS PER SHARE

Average shares outstanding               60,175    59,453    58,562

Net effect of dilutive stock options--
 based on the treasury stock method
 using average market price                 821       838     1,653
                                        -------   -------   -------

TOTAL                                    60,996    60,291    60,215
                                        =======   =======   =======

Net income                              $90,397   $69,955   $45,767
                                        =======   =======   =======

Per share amount                        $  1.48   $  1.16   $   .76
                                        =======   =======   =======

FULLY DILUTED EARNINGS PER SHARE

Average shares outstanding               60,175    59,453    58,562

Net effect of dilutive stock options--
 based on the treasury stock method
 using the year-end market price          1,013     1,032     1,746
                                        -------   -------   -------

TOTAL                                    61,188    60,485    60,308
                                        =======   =======   =======

Net income                              $90,397   $69,955   $45,767
                                        =======   =======   =======

Per share amount                        $  1.48   $  1.16   $   .76
                                        =======   =======   =======

<FN>
Note:  The fully diluted earnings per share calculation is submitted in 
       accordance with the Securities Exchange Act of l934 Release No. 9038
       although not required by footnote 2 to paragraph l4 of APB Opinion No. l5
       because it results in dilution of less than 3%.
</FN>
</TABLE>
<PAGE>   1

                            EL PASO NATURAL GAS COMPANY

                             EARNINGS PER COMMON SHARE
                               Form 10-Q, Exhibit 11
                       For The Three Months Ended March 31,
                     (In Thousands, except earnings per share)

<TABLE>
<CAPTION>
                                                    -----------------------
                                                      1997          1996
                                                    --------     ----------
<S>                                                 <C>          <C>

Income available for common stock dividends         $ 47,301     $ (35,248)

Primary average common shares outstanding             56,608        35,051
Primary earnings per share                          $ 0.8356     $ (1.0056)

Fully diluted average common shares outstanding       56,661        35,051
Fully diluted earnings per common share             $ 0.8348     $ (1.0056)

</TABLE>
#### § 635.23 Standards.

The use of NCIC is limited to authorized criminal justice purposes such as, stolen vehicle checks or wants and warrants. Subject to FBI regulations and policy, NCIC checks of visitors to a military installation may be authorized by the Installation/Garrison Commander as set forth in DoD 5200.08-R (Available at *http://www.dtic.mil/whs/directives/corres/pdf/520008r.pdf*) and DoDI 5200.08 (Available at *http://www.dtic.mil/whs/directives/corres/pdf/520008p.pdf*). Visitors to Army installations are non-DoD affiliated personnel.
#### STATE v. JACKSON

No. 562P97

Case below: 127 N.C.App. 562

Petition by defendant for discretionary review pursuant to G.S. 7A-31 denied 5 February 1998.
EXHIBIT
32(A)





Section
1350 Certification


By
Principal Executive Officer





I, Daniel
Greenberg, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that the periodic report,
to which this Statement is attached, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities and Exchange Act of 1934, and the
information contained in the periodic report to which this Statement is
attached, fairly presents, in all material respects, the financial condition and
results of operations of the registrant.





A
signed original of this written statement has been provided to the Company and
will be retained by the Company and furnished to the SEC upon
request.





Date:  December
23, 2008





/s/
      Daniel GreenbergDaniel
      Greenberg
                Chief
      Executive Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on December 28, 2020, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), R Consortium, Inc. (“R Consortium”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Stiftung für Qualitätssicherung und Transparenz im Gesundheitswesen, Berlin, GERMANY, has been added as a party to this venture.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and R Consortium intends to file additional written notifications disclosing all changes in membership.

                    On September 15, 2015, R Consortium filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on October 2, 2015 (80 FR 59815).                

                    The last notification was filed with the Department on October 1, 2020. A notice was published in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on October 15, 2020 (85 FR 65425).                

Suzanne Morris, 

Chief, Premerger and Division Statistics, Antitrust Division.

[FR Doc. 2021-00457 Filed 1-12-21; 8:45 am]

BILLING CODE 4410-11-P
##### 



Exhibit 99.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of the Erie Family Life Insurance
Company (the Company) on Form 10-Q for the period ended March 31, 2003 as
filed with the Securities and Exchange Commission on the date hereof (the
Report), we, Jeffrey A. Ludrof, Chief Executive Officer of the Company and
Philip A. Garcia, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act
of 2002, that:



| | (1) |  | The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and                              
| | --- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (2) |  | The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations
of the Company.



|/s/ Jeffrey A.
LudrofJeffrey A. Ludrof
President & Chief Executive Officer | 
|-------------------------------------------------------------------------- | 



|/s/ Philip A. GarciaPhilip A. Garcia
Senior VP & Chief Financial Officer | 
|------------------------------------------------------------------------ | 



|April 24, 2003 | 
|-------------- | 

A signed original of this written statement required by Section 906 has been
provided to Erie Family Life Insurance Company and will be retained by Erie
Family Life Insurance Company and furnished to the Securities and Exchange
Commission or its staff upon request.

27
II 

115TH CONGRESS 

1ST SESSION S. 531 

To amend the Intermodal Surface Transportation Efficiency Act of 1991 

to designate a portion of the Edward T. Breathitt Parkway as Interstate 

Route I-169. 

IN THE SENATE OF THE UNITED STATES 

MARCH 6, 2017 

Mr. PAUL introduced the following bill; which was read twice and referred to 

the Committee on Environment and Public Works 

A BILL 

To amend the Intermodal Surface Transportation Efficiency 

Act of 1991 to designate a portion of the Edward T. 

Breathitt Parkway as Interstate Route I-169. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ROUTE DESIGNATION. 

4 (a) HIGH PRIORITY CORRIDOR.—Section 1105(c) of 

5 the Intermodal Surface Transportation Efficiency Act of 

6 1991 (105 Stat. 2032; 129 Stat. 1422) is amended by 

7 adding at the end the following: 

8 ‘‘(89) Edward T. Breathitt (Pennyrile) Park9 way from its intersection with Interstate Route 24 


srobinson on DSK5SPTVN1PROD with BILLS
2 

•S 531 IS

1 to its intersection with Interstate 69 and the West2 ern Kentucky Parkway.’’. 

3 (b) INCLUSION OF CERTAIN ROUTES ON INTERSTATE

4 SYSTEM.—Section 1105(e)(5)(A) of the Intermodal Sur5 face Transportation Efficiency Act of 1991 (109 Stat. 

6 598; 118 Stat. 293; 129 Stat. 1422) is amended in the 

7 first sentence by striking ‘‘and subsection (c)(83)’’ and in8 serting ‘‘subsection (c)(83), and subsection (c)(89)’’. 

9 (c) DESIGNATION.—Section 1105(e)(5)(C)(i) of the 

10 Intermodal Surface Transportation Efficiency Act of 1991 

11 (109 Stat. 598; 126 Stat. 427; 129 Stat. 1422) is amend12 ed by adding at the end the following: ‘‘The route referred 

13 to in subsection (c)(89) is designated as Interstate Route 

14 I-169.’’. 

Æ 


srobinson on DSK5SPTVN1PROD with BILLS
§ 935.132 Speed limits. Each person operating a motor vehicle on Wake Island shall operate it at a speed— ( a ) That is reasonable, safe, and proper, considering time of day, road and weather conditions, the kind of motor vehicle, and the proximity to persons or buildings, or both; and
( b ) That does not exceed 40 miles an hour or such lesser speed limit as may be posted.